SMTL ID : 7r7l.1 (1 other biounit)

Structure of human SHP2 in complex with compound 30

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.00 Å

Oligo State

monomer

Ligands

1 x 3ED: 6-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-3-(2,3-dichlorophenyl)-2-methylpyrimidin-4(3H)-one(Non-covalent)

3ED.1: 14 residues within 4Å: Chain A: T.114, E.116, R.117, F.119, H.120, T.224, T.225, E.256, T.259, L.260, Q.263, P.497, K.498, Q.501 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:R.117, A:E.256, A:L.260, A:P.497, A:K.498, A:Q.501 Hydrogen bonds: A:E.116 Halogen bonds: A:T.259

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Czako, B. et al., Discovery of 6-[(3 S ,4 S )-4-Amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-3-(2,3-dichlorophenyl)-2-methyl-3,4-dihydropyrimidin-4-one (IACS-15414), a Potent and Orally Bioavailable SHP2 Inhibitor. J.Med.Chem. (2021)

Release Date

2021-10-27

Peptides

Tyrosine-protein phosphatase non-receptor type 11: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein phosphatase non-receptor type 11

Related Entries With Identical Sequence